Bimatoprost |
Lumigan |
Please wikify (format) this article or section as suggested in the Guide to layout and the Manual of Style. Remove this template after wikifying. This article has been tagged since April 2006. Drug used in the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; should be used in patients who are intolerant of other IOP-lowering medications or failed treatment with another IOP-lowering medication. Standard Dosage Ophthalmic: Adult: Open-an ...
Wikipedia - [full article]
Bimatoprost Clinical Trials
- 24-Hour IOP Control With the Bimatoprost/Timolol Fixed Combination
ClinicalTrials.gov Identifier: NCT00486486 - Recruiting
Exfoliative Glaucoma
- Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
ClinicalTrials.gov Identifier: NCT00187577 - Active, not recruiting
Alopecia Areata
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
ClinicalTrials.gov Identifier: NCT00440011 - Recruiting
Glaucoma; Ocular Hypertension
- Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
ClinicalTrials.gov Identifier: NCT00567788 - Active, not recruiting
Glaucoma, Angle-Closure
- A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00538304 - Recruiting
Glaucoma; Ocular Hypertension
- A Study of the Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00541242 - Not yet recruiting
Ocular Hypertension, Glaucoma
- Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
ClinicalTrials.gov Identifier: NCT00355446 - Completed
Cataract
- Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
ClinicalTrials.gov Identifier: NCT00347802 - Completed
Glaucoma
- Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
ClinicalTrials.gov Identifier: NCT00347841 - Completed
Glaucoma
- Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00348023 - Completed
Glaucoma
- A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00348062 - Completed
Glaucoma
- Internet-Based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
ClinicalTrials.gov Identifier: NCT00487214 - Completed
Glaucoma, Open-Angle
- Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00332059 - Completed
Ocular Hypertension
- Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00332540 - Completed
Ocular Hypertension
- Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00332072 - Completed
Ocular Hypertension
- Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00300443 - Completed
Ocular Hypertension

Not Signed In -


